ALFA Finder
India's fastest NSE & BSE filing alerts on Telegram, filtered to the stocks you hold
Telegram alerts
alfafinder.com →
ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
7 announcements with these filters
Record consolidated quarter, with HALS revenue doubling YoY. Standalone margins compressed as raw-material inflation could not be passed on to customers.
Q2 FY27 consolidated revenue ₹299 Cr (+22% YoY), PAT ₹56 Cr (+0.5%), EBITDA margin 31.2% (vs 36.4%). HALS-led growth; margins hit by geopolitical headwinds.
Clean Science reports record consolidated sales driven by the HALS segment scaling up, though legacy business faced raw material supply disruptions. Management is aggressively pivoting toward high-margin, advanced HALS chemistry via a new Swiss strategic collaboration.
Clean Science reported its highest-ever consolidated sales for Q1 FY27, reaching INR 268 Cr, driven by the HALS series expansion despite global headwinds.
Clean Science reported resilient Q4 FY26 performance with sequential revenue growth driven by HALS volume expansion. Standalone EBITDA margins remain robust at 46% despite global pricing pressures.
Clean Science shows sequential recovery in Q4 FY26 despite global pricing pressures, with management voluntarily forgoing bonuses to support financials amidst a 19% YoY standalone revenue decline.
Clean Science reports FY26 consolidated revenue of ₹957 cr and PAT of ₹230 cr. EBITDA margins remain resilient at 37.7% despite challenging market conditions, underpinned by new HALS product launches.